Progressive loss of IL-2-expandable HIV-1-specific cytotoxic T lymphocytes during asymptomatic HIV infection

European Journal of Immunology

Volumn 28, Issue 11, 1998, Pages 3564-3576

  Jin, Xia ^a,b   Wills, Mark ^a   Sissons, J G Patrick ^a   Carmichael, Andrew ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD8+; Cytotoxic T lymphocyte; Epstein Barr virus; HIV; Limiting dilution

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 12;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0031794557     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199811)28:11<3564::AID-IMMU3564>3.0.CO;2-J     Document Type: Article

References (38)

1. Yap, K., Ada, G. I. and McKenzie, I. F. C., Transfer of specific cytotoxic T lymphocytes protect mice inoculated with influenza virus. Nature 1978. 273: 238-239.
2. Del Val, M., Schlicht, H. J., Volkmer, H., Messerle, M., Reddehase, M. J. and Koszinowski, U. H., Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. J. Virol. 1991. 65: 3641-3646.
3. Johnson, E. D. and Cole, G. A., Functional heterogeneity of lymphocytic choriomeningitis virus-specific T lymphocytes. 1. Identification of effector and memory subsets. J. Exp. Med. 1975. 141: 866-878.
4. Borysiewicz, L. K., Hickling, J. K., Graham, S., Sinclair, J., Cranage, M. P., Smith, G. L. and Sissons, J. G. P., Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia virus. J. Exp. Med. 1988. 168: 919-931.
5. Murray, R. J., Kurilla, M. G., Brooks, J. M., Thomas, W. A., Rowe, M., Kieff, E. and Rickinson, A. B., Identification of target antigens for the human cytotoxic T cell response against Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp. Med. 1992. 176: 157-168.
6. + T-helper and a T-killer cell. Nature 1998. 393: 474-477.
7. Zinkernagel, R. M., Callahan, G. N., Althage, A., Cooper, S., Streilein, J. W. and Klein, J., The lymphoreticular system in triggering virus plus self-specific cytotoxic T cells: evidence for T help. J. Exp. Med. 1978. 147: 897-911.
8. Kast, W. M., Bronkhorst, A. M., de Waal, L. P. and Melief, C. J. M., Co-operation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. J. Exp. Med. 1986. 164: 723-738.
9. Leist, T. P., Kohler, M. and Zinkernagel, R. M., Impaired generation of anti-viral cytotoxicity against lymphocyte choriomeningitis and vaccinia virus in mice treated with CD4-specific monoclonal antibody. Scand. J. Immunol. 1989. 30: 679-686.
10. Buller, R. M. L., Holmes, K. L., Hugin, A., Frederickson, T. N. and Morse, H. D., Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 1987. 328: 77-79.
11. Ahmed, R., Butler, L. D. and Bhatti, L, T4+T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 1988. 62: 2102-2106.
12. + cells but markedly decreased helper cell activity in mice lacking CD4. Nature 1991. 353: 180-184.
13. Battegay, M., Moskophidis, D., Rahemtulla, A., Hengartner, H., Mak, T. W. and Zinkernagel, R. M., Enhanced establishment of a virus carrier state in adult CD4+ T cell-deficient mice. J. Virol. 1994. 68: 4700-4704.
14. + cytotoxic T cell responses during chronic infection. J. Virol. 1994. 68: 8056-8063.
15. Clerici, M., Stocks, N. I., Zajac, R. A., Boewell, R. N., Lucey, D. R., Via, C. S. and Shearer, G. M., Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J. Clin. Invest. 1989. 84: 1892-1829.
16. + T cell responses associated with control of viraemia. Science 1997. 278: 1447-1450.
17. Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C. and Ho, D. D., Temporal association of cellular immune responses with the initial control of viraemia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 1994. 68: 4650-4655.
18. Harrer, T., Harrer, E., Kalams, S. A., Barbosa, P., Trocha, A., Johnson, R. P., Elbeik, T., Feinberg, M. B., Buchbinder, S. P. and Walker, B. D., Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection: breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J. Immunol. 1996. 156: 2616-2623.
19. Riviere, Y., Tanneau-Salvadori, F., Regnault, A., Lopez, O., Sansonetti, P., Guy, B., Kieny, M.-P., Fournel, J.-J. and Montagnier, L., Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals. J. Virol. 1989. 63: 2270-2277.
20. Phillips, R. E., Rowland-Jones, S., Nixon, D. F., Gotcn, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G., Rothbard, J. A., Bangham, C. R. M., Rizza, C. R. and McMichael, A. J., Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991. 354: 453-459.
21. Klenerman, P., Rowland-Jones, S., McAdam, S., Edwards, J., Daenke, S., Lalloo, D., Köppe, B., Rosenberg, W., Boyd, D., Edwards, A., Giangrande, P., Phillips, R. E. and McMichael, A. J., Cytotoxic T-cell activity antagonized by naturally occurring HIV-gag variants. Nature 1994. 369: 403-407.
22. Haas, G., Plikat, U., Debré, P., Lusshiari, M., Katlama, C., Dudoit, Y., Bonduelle, O., Bauer, M., Ihlenfeldt, H.-G., Jung, G., Maier, B., Meyerhans, A. and Autran, B., Dynamics of viral variants in HIV-1 nef and specific cytotoxic T lymphocytes in vivo. J. Immunol. 1996. 157: 4212-4221.
23. Carmichael, A., Jin, X., Sissons, J. G. P. and Borysiewicz, L. K., Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of infection. J. Exp. Med. 1993. 177: 249-256.
24. Klein, M. R., van Baalen, C. A., Holwerda, A. M., Kerkhof Garde, S. R., Bende, R. J., Keet, I. P. M., Efftinck-Schattenkerk, J.-K. M., Osterhaus, A. D. M. E., Schuitemaker, H. and Miedema, F., Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection. J. Exp. Med. 1995. 181: 1365-1372.
25. Carmichael, A., Jin, X. and Sissons, J. G. P., Analysis of the human env-specific cytotoxic T lymphocyte response in natural human immunodeficiency virus type 1 infection. J. Virol. 1996. 70: 8468-8476.
26. Quentmeier, H., Klaucke, J., Mühlradt, P. F. and Drexler, H. G., Role of IL-6, IL-2, and IL-4 in the in vitro induction of cytotoxic T cells. J. Immunol. 1992. 149: 3316-3320.
27. Rogers, L. A., Zlotnick, A., Lee, F. and Snortman, K., Lymphokine requirements for the development of specific cytotoxic T cells from single precursors. Eur. J. Immunol. 1991. 21: 1069-1072.
28. + cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24. J. Virol. 1992. 66: 608-611.
29. + human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual. AIDS Res. Hum. Retroviruses 1993. 9: 61-68.
30. McMichael, A. J. and Walker, B. D., Cytotoxic T lymphocyte epitopes: implications for HIV vaccines. AIDS 1994. 8: S155-S173.
31. Reddehase, M. J., Cox, J. H. and Koszinowski, U. H., Frequency analysis of cytolytic T lymphocyte precursors (CTL-P) generated in vitro during lethal rabies infection of mice. Eur. J. Immunol. 1984. 14: 1039-1043.
32. Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Rasz, P., Tenner-Racz, K. and Haase, A. T., Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993. 362: 359-362.
33. Piatak, M., Saag, M. S., Yang, L. C., Clark, S. J., Kappes, J. C., Luk, K. C., Hahn, B. H., Shaw, G. M. and Lifson, J. D., High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993. 259: 1749-1754.
34. Moskophidis, D., Lechner, F., Pircher, H. and Zinkernagel, R. M., Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993. 362: 758-761.
35. Macatonia, S. E., Lau, R., Patterson, S., Pinching, A. J. and Knight, S. C., Dendritic cell infection, depletion, and dysfunction in HIV-infected individuals. Immunology 1990. 71: 38-45.
36. - T cells. AIDS 1994. 8: 431-441.
37. + T cells from HIV-infected persons. J. Immunol. 1994. 153: 412-420.
38. + T lymphocytes during HIV infection. J. Immunol. 1996. 156: 2282-2293.